Allergan (AGN) Declares $0.74 Quarterly Dividend; 2.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
FDA comments on new efforts to protect women’s health and help to ensure the safety of breast implants
May 2, 2019 2:53 PM EDTThere has been a growing discussion in recent months around the safety of certain breast implants, with regulatory agencies around the world weighing the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Its an issue that has been a priority for us at the U.S. Food and Drug Administration since 2011 when we warned women that the available information at the time indicated that there is a risk for women with breast implants, especially those with textured implants, for developing this disease.
Since that time, we have worked diligently to fill the gaps in knowledge, such as... More
Allergan (AGN) shareholder Appaloosa continues to believe separating roles of Chairman and CEO is necessary
May 1, 2019 11:12 AM EDTAppaloosa LP today issued a statement following Allergan plcs (NYSE: AGN) (Allergan) Annual General Meeting of Shareholders on May 1, 2019 regarding Allergan shareholders vote on Appaloosas proposal to separate the Chairman and CEO roles.
Allergan shareholders are clearly dissatisfied with managements performance,... More
Allergan (AGN) Announces Results from 2019 Annual General Meeting of Shareholders
May 1, 2019 7:25 AM EDTAllergan plc (NYSE: AGN) today announced the voting results, representing 85.9 percent of shares eligible to be voted, from its Annual General Meeting of Shareholders held on May 1, 2019 in Dublin, Ireland. Shareholders elected all of the 11 nominees as members of the Board of Directors, approved an advisory resolution on executive compensation, ratified the appointment of Allergan's independent auditor for fiscal year 2019, approved proposals related to the authority of the Directors to issue shares under certain specified conditions, and rejected a shareholder proposal calling for an immediate separation of... More
